Patient engagement is a crucial responsibility of any gene therapy company if they're serious about progressing safe, effective, and meaningful therapies to patients. The 4th Gene Therapy Patient Engagement Summit is returning in 2024, sitting at the unique interface of patient engagement and gene therapy, from embarking on first in-human trials through to commercial therapeutics. […]

AI and computational science are revolutionizing the field of RNA therapeutic discovery, which is empowering biopharma companies to harness the potential of this technology. Join the conversation at the world’s first industry-dedicated Computational RNA Design & Delivery Summit taking place in Boston this June 4 - 6 2024. Hear what industry pioneers from Sanofi, Moderna, Nava Therapeutics, Nutcracker Therapeutics, and […]

SAE Media Group’s 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can […]

The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as reduced cost, production and patient accessibility compared to its autologous counterparts. Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th […]

Driving Process Robustness, Scalability, Speed & Affordability In the dynamic cell therapy landscape, where financial challenges continue to prevail, the emphasis on innovative process development becomes pivotal. Now, more than ever, there's a heightened demand for cost-effective solutions that bolster scalability and expedite development timelines. Welcome to the 3rd Process Development for Cell Therapies Summit, […]

Harnessing Integrative Structural Biology Techniques Including NMR, X-Ray Crystallography, Cryo-EM, & Cryo-ET to Determine 3D Structures of Pharmacologically Relevant Targets & Propel Drug Design Have you heard the boom created by Cryo-EM? Drug development has been shaken up with the application of Cryo-EM, accelerating and increasing the rate of success of protein targeting by identifying […]

The 6th Age-Related Disease Therapeutics Summit is returning to San Francisco in June, with 60+ participants including Eli Lilly, Takeda, and Turn Biosciences to dive deep into breakthroughs in cellular programming, senolytic pathways, and epigenetic effects. Explore biomarkers, navigate regulations, and foster collaborations for pipeline support and commercialization. This is your definitive age-related disease therapeutics […]

Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) As a recent whitepaper by the Alliance for Regenerative Medicine cites capsid engineering and disruptive delivery platforms as key emerging technologies in the CGT space, drug developers are heavily investing in finding and optimizing the safety, efficacy, and […]

The highly anticipated World CDx Regulatory Affairs & Policy Summit, is set to debut in Boston from June 19-20, 2024. From tackling the complexities of LDT regulation and navigating the IVDR maze to understanding reimbursement dynamics, this groundbreaking meeting promises to provide clarity and harmonization in the realm of CDx regulation. Attendance is FREE for drug developers […]

Regulatory guidelines and existing protocols to govern aspects of mRNA quality during development and manufacturing are still evolving, creating a lack of clarity and consensus amongst the mRNA community. Without a clear path forward, drug developers risk comprising product quality, safety and efficacy, and so the 2nd mRNA Quality Control & Compliance Summit is back to […]

Cell and gene therapies are revolutionizing healthcare, offering promising solutions from curative treatments to long-term remission rates. As these treatments enter the market, ensuring fair access while addressing coverage and payment complexities becomes paramount.   Introducing the inaugural Cell & Gene Therapy Pricing & Reimbursement Summit. Biotech, pharma, physicians, healthcare providers, and regulatory and government agencies will unite to address key […]